Cost-effectiveness of fingolimod in treating patients with relapsing-remitting multiple sclerosis
Agashivala NV, Dastani HB, Carlton R, Sarnes E
Record Status
This is an economic evaluation that meets the criteria for inclusion on NHS EED.
Bibliographic details
Agashivala NV, Dastani HB, Carlton R, Sarnes E. Cost-effectiveness of fingolimod in treating patients with relapsing-remitting multiple sclerosis. American Journal of Pharmacy Benefits 2011; 3(6): 320-328